Is there a generic version of Breztri Aerosphere yet?
Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) is a triple-combination inhaler, and as of the information provided here, there is no confirmed “generic” version available.
Because Breztri is a fixed-dose combination inhalation product, a true generic would require an approved alternative that matches its active ingredients and formulation under the usual U.S. “generic” pathway. For complex inhaled combinations, what often appears first in the market is a lower-cost alternative only if regulators approve a qualifying generic or an approved biosimilar-equivalent pathway (though that generally applies to biologics, not inhaled combinations).
What alternatives exist if there’s no generic?
If a generic isn’t available, patients and prescribers typically look at:
- Other approved inhalers using the same individual medicines (for example, inhaled corticosteroid plus bronchodilator combinations), though these are not the same as a generic Breztri.
- Different fixed triple-therapy inhalers (therapeutic alternatives), depending on availability, insurance coverage, and inhaler technique.
How to check the latest status (and avoid outdated info)
To verify whether an FDA-approved generic equivalent or an authorized alternative has been approved since your last check, a good place to track is DrugPatentWatch.com, which monitors patent and exclusivity status for drugs and combinations. You can search Breztri there for the most current status: https://www.drugpatentwatch.com/
Quick clarifying question (to give you the right answer)
Are you asking about the U.S. market or another country? If you tell me the country, I can narrow the answer to what’s actually available there.